C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 1/20 (2006.01) A23C 9/123 (2006.01) A61K 35/74 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2359334
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Une souche de <i>Bifidobacterium</i>, issue du tractus gastro-intestinal humain, isolée et lavée, s'avère avoir une effet immunomodulateur notable après consommation par voie buccale. Cette souche se révèle des plus utile dans la prévention et/ou le traitement d'un état inflammatoire indésirable, notamment de la maladie intestinale inflammatoire ou du syndrome du côlon irritable. Cet état inflammatoire peut également être dû à un cancer.
Collins John Kevin
O'mahony Liam
O'sullivan Gerald Christopher
Shanahan Fergus
Enterprise Ireland (trading As Bioresearch Ireland)
Moffat & Co.
National University Of Ireland Cork
University College Cork - National University Of Ireland Cork
LandOfFree
Bifidobacterium in the treatment of inflammatory disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bifidobacterium in the treatment of inflammatory disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bifidobacterium in the treatment of inflammatory disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2082813